Indonesia’s healthcare sector is expanding rapidly, driven by sustained public investment in hospital infrastructure and growing demand for advanced medical technologies. This includes diagnostics, imaging equipment, surgical tools, patient monitoring systems, and hospital furniture. Because imports account for a significant share of medical device demand, the market offers strong opportunities for high-quality foreign suppliers.
The Canada–Indonesia Comprehensive Economic Partnership Agreement (CEPA) will enhance these opportunities by reducing tariffs and improving the competitiveness of Canadian medical devices in the Indonesian market.
Current most-favoured-nation (MFN) tariffs on Canadian medical devices generally range from 5% to 25%. Under the Canada-Indonesia Comprehensive Economic Partnership Agreement, most of these tariffs are expected to fall to zero within 5 to 10 years of the agreement entering into force. Some products will follow a longer phase-out schedule, while others will become duty-free immediately.